Published in Antimicrob Agents Chemother on August 01, 2006
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One (2010) 2.78
Antimicrobial peptides. Pharmaceuticals (Basel) (2013) 1.37
Antimicrobial peptides in human skin disease. Eur J Dermatol (2007) 1.17
Staphylococcus aureus mutant screen reveals interaction of the human antimicrobial peptide dermcidin with membrane phospholipids. Antimicrob Agents Chemother (2009) 1.16
Innate and adaptive immune responses against Staphylococcus aureus skin infections. Semin Immunopathol (2011) 1.12
Staphylococcus colonization of the skin and antimicrobial peptides. Expert Rev Dermatol (2010) 1.03
Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides. Int J Mol Sci (2014) 1.03
The potential of antimicrobial peptides as biocides. Int J Mol Sci (2011) 0.99
Structure and mode of action of microplusin, a copper II-chelating antimicrobial peptide from the cattle tick Rhipicephalus (Boophilus) microplus. J Biol Chem (2009) 0.98
Structure-activity analysis of the dermcidin-derived peptide DCD-1L, an anionic antimicrobial peptide present in human sweat. J Biol Chem (2012) 0.94
The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation. Skin Pharmacol Physiol (2012) 0.93
Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.92
Degradation of naturally occurring and engineered antimicrobial peptides by proteases. Adv Biosci Biotechnol (2011) 0.90
Sporicidal activity of synthetic antifungal undecapeptides and control of Penicillium rot of apples. Appl Environ Microbiol (2009) 0.86
Alternative approaches to antifungal therapies. Exp Dermatol (2012) 0.85
A cleavage-potentiated fragment of tear lacritin is bactericidal. J Biol Chem (2014) 0.84
Defending the fort: a role for defensin-2 in limiting Rickettsia montanensis infection of Dermacentor variabilis. Insect Mol Biol (2014) 0.81
Rondonin an antifungal peptide from spider (Acanthoscurria rondoniae) haemolymph. Results Immunol (2012) 0.78
On the role of NMR spectroscopy for characterization of antimicrobial peptides. Methods Mol Biol (2013) 0.77
Characterization of the antimicrobial peptide family defensins in the Tasmanian devil (Sarcophilus harrisii), koala (Phascolarctos cinereus), and tammar wallaby (Macropus eugenii). Immunogenetics (2016) 0.77
Hp1404, a new antimicrobial peptide from the scorpion Heterometrus petersii. PLoS One (2014) 0.77
Functional analysis of a novel cysteine-rich antimicrobial peptide from the salivary glands of the tick Rhipicephalus haemaphysaloides. Parasitol Res (2015) 0.77
Importance of residue 13 and the C-terminus for the structure and activity of the antimicrobial peptide aurein 2.2. Biophys J (2010) 0.76
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling. BMC Cancer (2015) 0.75
The in Vitro Immune-Modulating Properties of a Sweat Gland-Derived Antimicrobial Peptide Dermcidin. Shock (2016) 0.75
Antimicrobial Protection of Marsupial Pouch Young. Front Microbiol (2017) 0.75
Differential activity of innate defense antimicrobial peptides against Nocardia species. BMC Microbiol (2010) 0.75
Characterization of released polypeptides during an interferon-γ-dependent antibacterial response in airway epithelial cells. J Interferon Cytokine Res (2012) 0.75
pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents. Pharmaceuticals (Basel) (2016) 0.75
Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol (2005) 13.69
Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids (1970) 11.81
Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 11.11
Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta (1986) 7.07
Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev (2003) 6.57
Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem (1999) 6.44
Staphylococcus and biofilms. Mol Microbiol (2002) 6.39
Peptide antibiotics. Antimicrob Agents Chemother (1999) 5.76
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest (1989) 5.21
Cationic peptides: a new source of antibiotics. Trends Biotechnol (1998) 5.10
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06
Mammalian defensins in the antimicrobial immune response. Nat Immunol (2005) 4.84
Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry (1999) 3.88
How do bacteria resist human antimicrobial peptides? Trends Microbiol (2002) 3.76
Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol (2004) 3.26
Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 3.19
Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J (1999) 2.93
Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem (1998) 2.91
Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta (1998) 2.71
Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol (1998) 2.69
Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun (1998) 2.67
Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometry. J Immunol Methods (1988) 2.31
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother (1998) 2.06
MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol Lett (2004) 1.81
Antimicrobial peptides in health and disease. N Engl J Med (2002) 1.78
Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry (1995) 1.77
The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J (2006) 1.66
The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry (1997) 1.66
Membrane thinning effect of the beta-sheet antimicrobial protegrin. Biochemistry (2000) 1.64
Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity. Eur J Biochem (1997) 1.28
Effects of histatin 5 and derived peptides on Candida albicans. Biochem J (2001) 1.26
The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm. FEBS Lett (2001) 1.18
Antibacterial peptides and proteins with multiple cellular targets. J Pept Sci (2005) 1.17
Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: determination and biological specificity. Biochim Biophys Acta (1999) 1.16
Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol (2005) 1.16
Cathepsin D is present in human eccrine sweat and involved in the postsecretory processing of the antimicrobial peptide DCD-1L. J Biol Chem (2005) 1.12
Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis. FEMS Microbiol Lett (2004) 1.06
Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br J Dermatol (2004) 1.04
Functions of antimicrobial peptides in host defense and immunity. Curr Protein Pept Sci (2005) 1.04
Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites. J Invest Dermatol (2006) 0.99
Specific interactions of the antimicrobial peptide cyclic beta-sheet tachyplesin I with lipopolysaccharides. Biochim Biophys Acta (2002) 0.92
Detection of dermcidin-derived peptides in sweat by ProteinChip technology. J Immunol Methods (2002) 0.87
Functional and structural characterization of recombinant dermcidin-1L, a human antimicrobial peptide. Biochem Biophys Res Commun (2005) 0.86
Expression and purification of human antimicrobial peptide, dermcidin, in Escherichia coli. Protein Expr Purif (2005) 0.86
The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun (1999) 7.22
Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol (1996) 7.16
Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem (1999) 6.44
Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol (1997) 5.47
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science (1999) 5.30
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06
Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature (1988) 4.41
Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis (2000) 4.19
Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation. Infect Immun (1996) 3.95
Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J Biol Chem (1998) 3.80
Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun (1997) 3.71
Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur J Biochem (1992) 3.54
A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by alternating insertion and excision of the insertion sequence element IS256. Mol Microbiol (1999) 3.48
Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation. FEMS Microbiol Lett (1990) 3.45
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol (2009) 3.45
A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol (1997) 3.25
Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect Immun (2001) 2.96
Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun (2001) 2.72
The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob Agents Chemother (2000) 2.71
Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol (1998) 2.69
Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol (2009) 2.56
Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur J Biochem (1988) 2.32
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
Human melanoma progression in skin reconstructs : biological significance of bFGF. Am J Pathol (2000) 2.23
Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Lett (1999) 2.16
Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J Infect Dis (2001) 2.10
Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4'-diaponeurosporene of Staphylococcus aureus. J Bacteriol (1994) 2.07
Laparoscopic appendectomy in 625 cases: from innovation to routine. Surg Laparosc Endosc (1991) 2.07
Expression and regulation of the antimonite, arsenite, and arsenate resistance operon of Staphylococcus xylosus plasmid pSX267. J Bacteriol (1992) 2.06
Structure of the pheromone peptide of the Staphylococcus epidermidis agr system. FEBS Lett (1998) 1.96
Analysis of genes involved in the biosynthesis of lantibiotic epidermin. Eur J Biochem (1992) 1.94
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer (2009) 1.93
Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol (2000) 1.92
Inducible production and cellular location of the epidermin biosynthetic enzyme EpiB using an improved staphylococcal expression system. FEMS Microbiol Lett (1996) 1.81
Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. Br J Dermatol (1999) 1.79
Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol (2002) 1.71
Oxygen utilization by Lactobacillus plantarum. I. Oxygen consuming reactions. Arch Microbiol (1980) 1.71
Plasmid transfer and genetic recombination by protoplast fusion in staphylococci. J Bacteriol (1981) 1.70
Problems in defining cutoff points of continuous prognostic factors: example of tumor thickness in primary cutaneous melanoma. J Clin Epidemiol (1997) 1.69
The dermatoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris. Dermatology (2001) 1.66
Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol (1996) 1.65
Trefoil factor family-peptides promote migration of human bronchial epithelial cells: synergistic effect with epidermal growth factor. Am J Respir Cell Mol Biol (2001) 1.65
Purification and biochemical characterization of pyruvate oxidase from Lactobacillus plantarum. J Bacteriol (1984) 1.64
Two new proteases in the MHC class I processing pathway. Nat Immunol (2000) 1.63
Expression of the gene encoding protein A in Staphylococcus aureus and coagulase-negative staphylococci. J Bacteriol (1984) 1.61
Comparative analysis of a biofilm-forming Staphylococcus epidermidis strain and its adhesion-positive, accumulation-negative mutant M7. FEMS Microbiol Lett (1994) 1.60
Pheromone cross-inhibition between Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun (2001) 1.59
Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations. Cancer (1997) 1.59
Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J Biol Chem (1998) 1.57
Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Br J Dermatol (2001) 1.56
DNA homology between the arsenate resistance plasmid pSX267 from Staphylococcus xylosus and the penicillinase plasmid pI258 from Staphylococcus aureus. Plasmid (1983) 1.56
Protein engineering of lantibiotics. Antonie Van Leeuwenhoek (1996) 1.54
Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus. Mol Microbiol (1997) 1.54
Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol (1998) 1.54
Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic. FEMS Microbiol Lett (1989) 1.53
Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. Br J Dermatol (2007) 1.49
Dermoscopic classification of atypical melanocytic nevi (Clark nevi). Arch Dermatol (2001) 1.49
Limit of T cell tolerance to self proteins by peptide presentation. Science (1990) 1.49
A promoter-screening plasmid and xylose-inducible, glucose-repressible expression vectors for Staphylococcus carnosus. Gene (1995) 1.48
Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol (1992) 1.47
The molecular organization of the lysostaphin gene and its sequences repeated in tandem. Mol Gen Genet (1987) 1.47
Analysis of the Staphylococcus epidermidis genes epiF, -E, and -G involved in epidermin immunity. J Bacteriol (1996) 1.46
[Laparoscopic placement of T-drainage in choledocholithiasis]. Chirurg (1991) 1.43
Basal cell carcinoma: histological classification and body-site distribution. Br J Dermatol (2006) 1.43
Regulation of epidermin biosynthetic genes by EpiQ. Mol Microbiol (1993) 1.42
Staphylococcal lipases: biochemical and molecular characterization. Biochimie (2000) 1.42
Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells. Leukemia (2009) 1.40
Organization, promoter analysis and transcriptional regulation of the Staphylococcus xylosus xylose utilization operon. Mol Gen Genet (1991) 1.40
[Elective lymph node dissection in primary malignant melanoma]. Hautarzt (1996) 1.39
Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis. Infect Immun (2000) 1.39
The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate. Antimicrob Agents Chemother (2009) 1.38
[Merkel cell tumor of the skin]. Dtsch Med Wochenschr (1997) 1.38
Modified Gittes's needle colposuspension method complemented with the laparoscopic ventrosuspension of the uterus for the treatment of stress incontinence associated with stage III or IV pelvic organ prolapse. Am J Obstet Gynecol (1997) 1.38
Chemical and biochemical studies for the differentiation of coagulase-positive staphylococci. Arch Microbiol (1976) 1.38
Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance. J Am Acad Dermatol (1996) 1.38
Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3. Cancer Res (1997) 1.38
Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer (2010) 1.37
Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci (2005) 1.35
Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. Eur J Cell Biol (2000) 1.34
Association of statin use with cognitive decline in elderly African Americans. Neurology (2007) 1.34
Complete nucleotide sequence of the lipase gene from Staphylococcus hyicus cloned in Staphylococcus carnosus. Nucleic Acids Res (1985) 1.34
Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol (1994) 1.32
Multiple activities in lantibiotics--models for the design of novel antibiotics? Curr Pharm Des (2002) 1.32
Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Scand J Immunol (2007) 1.32
Oxidative decarboxylation of peptides catalyzed by flavoprotein EpiD. Determination of substrate specificity using peptide libraries and neutral loss mass spectrometry. J Biol Chem (1995) 1.32
Further characterization of Staphylococcus epidermidis transposon mutants deficient in primary attachment or intercellular adhesion. Zentralbl Bakteriol (1998) 1.30
Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol (2000) 1.29
Glucose kinase-dependent catabolite repression in Staphylococcus xylosus. J Bacteriol (1995) 1.28
Cloning, expression and characterization of the Sau3AI restriction and modification genes in Staphylococcus carnosus TM300. Gene (1990) 1.28
Posttranslationally modified bacteriocins--the lantibiotics. Biopolymers (2000) 1.27
Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy. J Cutan Pathol (2000) 1.27